+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

From
From
From
Gene Therapy R&D Market Report 2024-2034 - Product Thumbnail Image

Gene Therapy R&D Market Report 2024-2034

  • Report
  • May 2024
  • 340 Pages
  • Global
From
Cancer Biologics Market Report 2023-2033 - Product Thumbnail Image

Cancer Biologics Market Report 2023-2033

  • Report
  • June 2023
  • 308 Pages
  • Global
From
From
Regenerative Medicine Market Report 2023-2033 - Product Thumbnail Image

Regenerative Medicine Market Report 2023-2033

  • Report
  • March 2023
  • 232 Pages
  • Global
From
Targeted Protein Degradation - Global Strategic Business Report - Product Thumbnail Image

Targeted Protein Degradation - Global Strategic Business Report

  • Report
  • August 2025
  • 384 Pages
  • Global
From
Vaccines Market 2025-2029 - Product Thumbnail Image

Vaccines Market 2025-2029

  • Report
  • January 2025
  • 194 Pages
  • Global
From
Protein Kinase C Theta Type - Pipeline Review, H2 2020 - Product Thumbnail Image

Protein Kinase C Theta Type - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 33 Pages
  • Global
From
Tyrosine Kinase Inhibitors - Global Strategic Business Report - Product Thumbnail Image

Tyrosine Kinase Inhibitors - Global Strategic Business Report

  • Report
  • August 2025
  • 290 Pages
  • Global
From
Loading Indicator